{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:44:57Z","timestamp":1793263497197,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009526","name":"Amrita Vishwa Vidyapeetham University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bcp.2020.114135","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T11:17:54Z","timestamp":1593775074000},"page":"114135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Snake antivenom: Challenges and alternate approaches"],"prefix":"10.1016","volume":"181","author":[{"given":"Aswathy","family":"Alangode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthika","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin G.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114135_b0005","first-page":"515","article-title":"Snake-bites: appraisal of the global situation","volume":"76","author":"Chippaux","year":"1998","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.bcp.2020.114135_b0010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.bcp.2020.114135_b0015","doi-asserted-by":"crossref","unstructured":"J.M. Guti\u00e9rrez, J.J. Calvete, A.G. Habib, R.A. Harrison, D.J. Williams, D.A. Warrell, Snakebite envenoming, Nat. Rev. Dis. Prim. (2017).","DOI":"10.1038\/nrdp.2017.63"},{"key":"10.1016\/j.bcp.2020.114135_b0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.toxicon.2015.11.013","article-title":"Understanding and confronting snakebite envenoming: the harvest of cooperation","volume":"109","author":"Guti\u00e9rrez","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0025","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1111\/j.1742-4658.2011.08115.x","article-title":"Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis","volume":"278","author":"Kang","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2020.114135_b0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxicon.2012.09.008","article-title":"Non-enzymatic proteins from snake venoms: a gold mine of pharmacological tools and drug leads","volume":"62","author":"McCleary","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins11040193","article-title":"Long-term effects of snake envenoming","volume":"11","author":"Waiddyanatha","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins10110452","article-title":"Innovative immunization strategies for antivenom development","volume":"10","author":"Berm\u00fadez-M\u00e9ndez","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0045","unstructured":"WHO, Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins, World Heal. Organ. (2016) 1\u2013138."},{"key":"10.1016\/j.bcp.2020.114135_b0050","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0041-0101(91)90116-9","article-title":"Snake venom variability: methods of study results and interpretation","volume":"29","author":"Chippaux","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12739","article-title":"Adverse reactions to snake antivenom, and their prevention and treatment","volume":"81","author":"De Silva","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114135_b0060","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries","volume":"23","author":"Hoogenboom","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2020.114135_b0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00003495-199958010-00002","article-title":"Antivenom therapy in the Americas","volume":"58","author":"Heard","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2020.114135_b0070","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0041-0101(98)00140-8","article-title":"The development and use of immunotherapy in Africa","volume":"36","author":"Chippaux","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0075","unstructured":"World Health Organization, Progress in the characterization of venoms and standardization of antivenoms, 1981."},{"key":"10.1016\/j.bcp.2020.114135_b0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2013.09.010","article-title":"Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms","volume":"76","author":"Le\u00f3n","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S1726-4901(10)70117-9","article-title":"Antivenin-related serum sickness","volume":"73","author":"Huang","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.bcp.2020.114135_b0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5694\/j.1326-5377.1994.tb138191.x","article-title":"Premedication for snake antivenom","volume":"160","author":"Tibballs","year":"1994","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bcp.2020.114135_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000435","article-title":"Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"de Silva","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.bcp.2020.114135_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40409-018-0144-0","article-title":"Antivenom therapy: efficacy of premedication for the prevention of adverse reactions","volume":"24","author":"Morais","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.bcp.2020.114135_b0105","unstructured":"A.S. Hertzberg SR, A life-threatening anaphylactoid reaction to polyvalent snake antivenom despite pretreatment, n.d."},{"key":"10.1016\/j.bcp.2020.114135_b0110","doi-asserted-by":"crossref","unstructured":"I. Nuchprayoon, P. Garner, Interventions for preventing reactions to snake antivenom, Cochrane Database Syst. Rev. (1999).","DOI":"10.1002\/14651858.CD002153"},{"key":"10.1016\/j.bcp.2020.114135_b0115","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/11592050-000000000-00000","article-title":"Effect of pre-medication on early adverse reactions following antivenom use in snakebite: a systematic review and meta-analysis","volume":"34","author":"Habib","year":"2011","journal-title":"Drug Saf."},{"key":"10.1016\/j.bcp.2020.114135_b0120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0030-1254053","article-title":"Snakebite doesn\u2019t cause disseminated intravascular coagulation: Coagulopathy and thrombotic microangiopathy in snake envenoming","volume":"36","author":"Isbister","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcp.2020.114135_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003220","article-title":"Current treatment for venom-induced consumption coagulopathy resulting from snakebite","volume":"8","author":"Maduwage","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bcp.2020.114135_b0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/qjmed\/hcp081","article-title":"Failure of antivenom to improve recovery in Australian snakebite coagulopathy","volume":"102","author":"Isbister","year":"2009","journal-title":"Qjm"},{"key":"10.1016\/j.bcp.2020.114135_b0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-0029-1214152","article-title":"Procoagulant snake toxins: laboratory studies, diagnosis, and understanding snakebite coagulopathy","volume":"35","author":"Isbister","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcp.2020.114135_b0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.toxicon.2008.08.013","article-title":"A model for venom-induced consumptive coagulopathy in snake bite","volume":"52","author":"Tanos","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.11.001","article-title":"Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP-17)","volume":"61","author":"Gulati","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.toxicon.2013.09.003","article-title":"Hemostasis dynamics during coagulopathy resulting from Echis envenomation","volume":"76","author":"Mion","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0155","doi-asserted-by":"crossref","unstructured":"A. Rogalski, C. Soerensen, B. op den Brouw, C. Lister, D. Dashvesky, K. Arbuckle, A. Gloria, C.N. Zdenek, N.R. Casewell, J.M. Guti\u00e9rrez, W. W\u00fcster, S.A. Ali, P. Masci, P. Rowley, N. Frank, B.G. Fry, Differential procoagulant effects of saw-scaled viper (Serpentes: Viperidae: Echis) snake venoms on human plasma and the narrow taxonomic ranges of antivenom efficacies, Toxicol. Lett. 280 (2017) 159\u2013170.","DOI":"10.1016\/j.toxlet.2017.08.020"},{"key":"10.1016\/j.bcp.2020.114135_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011428","article-title":"Snake antivenom for snake venom induced consumption coagulopathy","volume":"2014","author":"Maduwage","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcp.2020.114135_b0165","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/1740774514543538","article-title":"Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation","volume":"11","author":"Gerardo","year":"2014","journal-title":"Clin. Trials"},{"key":"10.1016\/j.bcp.2020.114135_b0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cbpc.2017.07.005","article-title":"Catch a tiger snake by its tail: differential toxicity, co-factor dependence and antivenom efficacy in a procoagulant clade of Australian venomous snakes","volume":"202","author":"Lister","year":"2017","journal-title":"Comp. Biochem. Physiol. Part - C Toxicol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114135_b0175","doi-asserted-by":"crossref","unstructured":"C.N. Zdenek, B. op den Brouw, D. Dashevsky, A. Gloria, N.J. Youngman, E. Watson, P. Green, C. Hay, N. Dunstan, L. Allen, B.G. Fry, Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms, Toxicol. Lett. 316 (2019) 171\u2013182.","DOI":"10.1016\/j.toxlet.2019.08.014"},{"key":"10.1016\/j.bcp.2020.114135_b0180","doi-asserted-by":"crossref","unstructured":"C.N. Zdenek, C. Hay, K. Arbuckle, T.N.W. Jackson, M.H.A. Bos, B. op den Brouw, J. Debono, L. Allen, N. Dunstan, T. Morley, M. Herrera, J.M. Guti\u00e9rrez, D.J. Williams, B.G. Fry, Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom, Toxicol. Vitr. 58 (2019) 97\u2013109.","DOI":"10.1016\/j.tiv.2019.03.031"},{"key":"10.1016\/j.bcp.2020.114135_b0185","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ijbiomac.2020.01.226","article-title":"Delineating the venom toxin arsenal of Malabar pit viper (Trimeresurus malabaricus) from the Western Ghats of India and evaluating its immunological cross-reactivity and in vitro cytotoxicity","volume":"148","author":"Vanuopadath","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2020.114135_b0190","doi-asserted-by":"crossref","unstructured":"R.R. Senji Laxme, S. Khochare, H.F. de Souza, B. Ahuja, V. Suranse, G. Martin, R. Whitaker, K. Sunagar, Beyond the \u2018Big four\u2019: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies, 2019.","DOI":"10.1371\/journal.pntd.0007899"},{"key":"10.1016\/j.bcp.2020.114135_b0195","first-page":"8","article-title":"Antivenomics of Atropoides mexicanus and Atropoides picadoi snake venoms: relationship to the neutralization of toxic and enzymatic activities","volume":"1","author":"Ant\u00fanez","year":"2010","journal-title":"J. Venom Res."},{"key":"10.1016\/j.bcp.2020.114135_b0200","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/pr9009518","article-title":"Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: integrating antivenomics and neutralization approaches","volume":"9","author":"Guti\u00e9rrez","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bcp.2020.114135_b0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.toxlet.2019.09.003","article-title":"Clinical implications of differential antivenom efficacy in neutralising coagulotoxicity produced by venoms from species within the arboreal viperid snake genus Trimeresurus","volume":"316","author":"Debono","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2020.114135_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.05.001","article-title":"Clinical studies of the effectiveness and safety of antivenoms","volume":"150","author":"Williams","year":"2018","journal-title":"Toxicon."},{"key":"10.1016\/j.bcp.2020.114135_b0215","first-page":"1","article-title":"Tropical medicine and infectious disease recent advances in next generation snakebite antivenoms","volume":"3","author":"Knudsen","year":"2018","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.bcp.2020.114135_b0220","first-page":"1","article-title":"Current research into snake antivenoms, their mechanisms of action and applications","author":"Silva","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bcp.2020.114135_b0225","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.imr.2017.03.001","article-title":"Ethnomedicinal plants used for snakebite in India: a brief overview","volume":"6","author":"Upasani","year":"2017","journal-title":"Integr. Med. Res."},{"key":"10.1016\/j.bcp.2020.114135_b0230","article-title":"Medicinal plants for the treatment of local tissue damage induced by snake venoms: an overview from traditional use to pharmacological evidence, evidence-based complement","volume":"2017","author":"F\u00e9lix-Silva","year":"2017","journal-title":"Altern. Med."},{"key":"10.1016\/j.bcp.2020.114135_b0235","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0041-0101(87)90156-5","article-title":"Interaction of phospholipase A2 from Vipera russelli venom with aristolochic acid: a circular dichroism study","volume":"25","author":"Vishwanath","year":"1987","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0240","first-page":"21","article-title":"Antisnake venom properties of medicinal plants","volume":"7","author":"Janardhan","year":"2015","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.bcp.2020.114135_b0245","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3109\/13880209.2015.1123729","article-title":"Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: an in vitro and in silico study","volume":"54","author":"Madhusudan","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bcp.2020.114135_b0250","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.toxicon.2008.03.021","article-title":"Isolation of a snake venom phospholipase A2 (PLA2) inhibitor (AIPLAI) from leaves of Azadirachta indica (Neem): Mechanism of PLA2 inhibition by AIPLAI in vitro condition","volume":"51","author":"Mukherjee","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/antib8030044","article-title":"Phage display libraries for antibody therapeutic discovery and development","volume":"8","author":"Almagro","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.bcp.2020.114135_b0260","unstructured":"N.A.-S., C.M. Modahl, Snakebite Therapeutics Based on Endogenous Inhibitors from Vipers., Intech. (2016) 13."},{"key":"10.1016\/j.bcp.2020.114135_b0265","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2010.04.024","article-title":"Up-regulation of the expressions of phospholipase A2 inhibitors in the liver of a venomous snake by its own venom phospholipase A2","volume":"395","author":"Kinkawa","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2020.114135_b0270","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.toxicon.2009.01.038","article-title":"Experimental pathology of local tissue damage induced by Bothrops asper snake venom","volume":"54","author":"Guti\u00e9rrez","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003731","article-title":"Tissue localization and extracellular matrix degradation by PI, PII and PIII snake venom metalloproteinases: clues on the mechanisms of venom-induced hemorrhage","volume":"9","author":"Herrera","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bcp.2020.114135_b0280","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.toxicon.2003.11.002","article-title":"Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes","volume":"42","author":"Kini","year":"2003","journal-title":"Toxicon."},{"key":"10.1016\/j.bcp.2020.114135_b0285","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.toxicon.2009.12.023","article-title":"Venom neutralization by purified bioactive molecules: Synthetic peptide derivatives of the endogenous PLA2 inhibitory protein PIP (a mini-review)","volume":"56","author":"Thwin","year":"2010","journal-title":"Toxicon."},{"key":"10.1016\/j.bcp.2020.114135_b0290","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1006\/bbrc.1998.9017","article-title":"Characterization of three endogenous peptide inhibitors for multiple metalloproteinases with fibrinogenolytic activity from the venom of Taiwan habu (Trimeresurus mucrosquamatus)","volume":"248","author":"Huang","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2020.114135_b0295","article-title":"Snake venom metalloproteinases and their peptide inhibitors from Myanmar Russell\u2019s viper venom","volume":"9","author":"Yee","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0300","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbrc.2007.11.027","article-title":"Molecular characterisation of endogenous snake venom metalloproteinase inhibitors","volume":"365","author":"Wagstaff","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2020.114135_b0305","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1046\/j.1432-1327.2001.02199.x","article-title":"BJ46a, a snake venom metalloproteinase inhibitor isolation, characterization, cloning and insights into its mechanism of action","volume":"268","author":"Valente","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2020.114135_b0310","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jprot.2011.05.027","article-title":"Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa","volume":"74","author":"Williams","year":"2011","journal-title":"J. Proteomics"},{"key":"10.1016\/j.bcp.2020.114135_b0315","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jprot.2016.05.020","article-title":"Screening for target toxins of the antiophidic protein DM64 through a gel-based interactomics approach","volume":"151","author":"Rocha","year":"2017","journal-title":"J. Proteomics"},{"key":"10.1016\/j.bcp.2020.114135_b0320","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/S0104-79301999000100005","article-title":"Anti-lethal factor from opossum serum is a potent antidote for animal, plant and bacterial toxins","volume":"5","author":"Lipps","year":"1999","journal-title":"J. Venom. Anim. Toxins."},{"key":"10.1016\/j.bcp.2020.114135_b0325","first-page":"139","article-title":"Opossum peptide that can neutralize rattlesnake venom is expressed in Escherichia coli","volume":"176","author":"Claire","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bcp.2020.114135_b0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/11533650-000000000-00000","article-title":"Varespladib","volume":"11","author":"Drugs","year":"2011","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.bcp.2020.114135_b0335","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jprot.2014.02.027","article-title":"Eastern coral snake Micrurus fulvius venom toxicity in mice is mainly determined by neurotoxic phospholipases A2","volume":"105","author":"Vergara","year":"2014","journal-title":"J. Proteomics"},{"key":"10.1016\/j.bcp.2020.114135_b0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.toxicon.2014.07.010","article-title":"Intravascular hemolysis induced by the venom of the Eastern coral snake, Micrurus fulvius, in a mouse model: identification of directly hemolytic phospholipases A2","volume":"90","author":"Arce-Bejarano","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0345","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.toxicon.2011.11.009","article-title":"Myotoxicity and nephrotoxicity by Micrurus venoms in experimental envenomation","volume":"59","author":"De Roodt","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10110479","article-title":"Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue juvenile pigs from lethal doses of micrurus fulvius (eastern coral snake) venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8090248","article-title":"Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10120516","article-title":"Coagulotoxic cobras: clinical implications of strong anticoagulant actions of african spitting naja venoms that are not neutralised by antivenom but are by LY315920 (varespladib)","volume":"10","author":"Bittenbinder","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0365","article-title":"Exploration of the inhibitory potential of varespladib for snakebite envenomation","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2020.114135_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53755-5","article-title":"Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920)","volume":"9","author":"Salvador","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114135_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12020131","article-title":"Varespladib (LY315920) and methyl varespladib (LY333013) abrogate or delay lethality induced by presynaptically acting neurotoxic snake venoms","volume":"12","author":"Guti\u00e9rrez","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0380","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.toxlet.2020.05.014","article-title":"Anticoagulant activity of black snake (Elapidae: Pseudechis) venoms: mechanisms, potency, and antivenom efficacy","volume":"330","author":"Zdenek","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2020.114135_b0385","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6592820","article-title":"Snake venom PLA2, a promising target for broad-spectrum antivenom drug development","volume":"2017","author":"Xiao","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2020.114135_b0390","doi-asserted-by":"crossref","unstructured":"J.M. Guti\u00e9rrez, A. Rucavado, Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage, Biochimie 82 (2000) 841\u2013850.","DOI":"10.1016\/S0300-9084(00)01163-9"},{"key":"10.1016\/j.bcp.2020.114135_b0395","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4800(84)90054-6","article-title":"Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper","volume":"40","author":"Guti\u00e9rrez","year":"1984","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bcp.2020.114135_b0400","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0014-4800(92)90004-U","article-title":"Ultrastructural alterations in mouse capillary blood vessels after experimental injection of venom from the snake Bothrops asper (Terciopelo)","volume":"57","author":"Moreira","year":"1992","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bcp.2020.114135_b0405","doi-asserted-by":"crossref","unstructured":"B. Lomonte, J. Lundgren, B. Johansson, U. Bagge, The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study, Toxicon 32 (1994) 41\u201355.","DOI":"10.1016\/0041-0101(94)90020-5"},{"key":"10.1016\/j.bcp.2020.114135_b0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0041-0101(94)00135-U","article-title":"Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice","volume":"33","author":"Chaves","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0415","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.toxicon.2004.01.016","article-title":"Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation","volume":"43","author":"Rucavado","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0420","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4269\/ajtmh.2000.63.313","article-title":"Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA","volume":"63","author":"Rucavado","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bcp.2020.114135_b0425","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-2952(00)00302-6","article-title":"Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper","volume":"60","author":"Escalante","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114135_b0430","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.toxicon.2006.11.020","article-title":"Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators","volume":"49","author":"Howes","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0435","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2017.04.001","article-title":"Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom","volume":"132","author":"Arias","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24183276","article-title":"Perspective on the therapeutics of anti-snake venom","volume":"24","author":"G\u00f3mez-Betancur","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2020.114135_b0445","doi-asserted-by":"crossref","unstructured":"S. GP, Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface, Science (80-.), 228 (1985) 1315\u20131317.","DOI":"10.1126\/science.4001944"},{"key":"10.1016\/j.bcp.2020.114135_b0450","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: filamentous phage displaying antibody variable domains","volume":"348","author":"McCafferty","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114135_b0455","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.tibtech.2010.03.007","article-title":"Multivalent antibodies: when design surpasses evolution","volume":"28","author":"Cuesta","year":"2010","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bcp.2020.114135_b0460","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1742-7843.2011.00821.x","article-title":"Production of human antibody fragments binding to melittin and phospholipase A2 in Africanised bee venom: minimising venom toxicity","volume":"110","author":"Funayama","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2020.114135_b0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins10100393","article-title":"Antibody cross-reactivity in antivenom research","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2020.114135_b0470","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(95)02095-0","article-title":"Specificity and binding affinity of an anti-crotoxin combinatorial antibody selected from a phage-displayed library","volume":"50","author":"Jianxin","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114135_b0475","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2174\/138161207782023784","article-title":"Trends in snakebite envenomation therapy: scientific, technological and public health considerations","volume":"13","author":"Gutierrez","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2020.114135_b0480","doi-asserted-by":"crossref","unstructured":"E.C. Roncolato, L.B. Campos, G. Pessenda, L. Costa E Silva, G.P. Furtado, J.E. Barbosa, Phage display as a novel promising antivenom therapy: a review, Toxicon 93 (2015) 79\u201384.","DOI":"10.1016\/j.toxicon.2014.11.001"},{"key":"10.1016\/j.bcp.2020.114135_b0485","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.toxicon.2018.10.124","article-title":"Application of phage display for the development of a novel inhibitor of PLA2 activity in western cottonmouth venom","volume":"158","author":"Titus","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0490","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0041-0101(98)00145-7","article-title":"Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom","volume":"36","author":"Guti\u00e9rrez","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114135_b0495","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120021113","article-title":"Snake antivenoms","volume":"41","author":"Lalloo","year":"2003","journal-title":"J. Toxicol. - Clin. Toxicol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:17:35Z","timestamp":1757769455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":99,"alternative-id":["S0006295220303713"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114135","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Snake antivenom: Challenges and alternate approaches","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114135"}}